Back to News

Recipharm Harmonizes its Global Quality Operations with ³Ô¹Ï±¬ÁÏ Quality Cloud

Leading CDMO adopts ³Ô¹Ï±¬ÁÏ QMS, ³Ô¹Ï±¬ÁÏ QualityDocs, and ³Ô¹Ï±¬ÁÏ Training to standardize quality processes and manage GxP content across its organization

BARCELONA, Spain ¡ª 19 Dec. 2023 ¡ª ³Ô¹Ï±¬ÁÏ Systems (NYSE: VEEV) today announced that , a global contract development and manufacturing organization (CDMO), will use ³Ô¹Ï±¬ÁÏ QMS, ³Ô¹Ï±¬ÁÏ QualityDocs, and ³Ô¹Ï±¬ÁÏ Training to streamline its quality operations. ³Ô¹Ï±¬ÁÏ quality applications will help Recipharm achieve greater quality oversight, use resources more effectively, accelerate validation, and maintain inspection readiness.

¡°Harmonizing quality processes and GxP documentation across Recipharm sites will make our quality operations more efficient and scalable,¡± said Vanessa Nardolillo, head of quality management and regulatory affairs at Recipharm. ¡°With ³Ô¹Ï±¬ÁÏ Quality Cloud, Recipharm is setting a new global standard for quality management, site collaboration, and compliance. The system will enable us to provide our customers with a standard approach to quality. It forms a key part of our focus on continuous improvement, to unleash excellence in quality across our services.¡±

Recipharm offers manufacturing services to pharmaceutical and medical device companies. ³Ô¹Ï±¬ÁÏ QMS will help Recipharm gain greater control and visibility into quality processes, with ³Ô¹Ï±¬ÁÏ QualityDocs, driving efficient GxP content management and information sharing among sites. With ³Ô¹Ï±¬ÁÏ Training, Recipharm can deploy learning content and curricula to help ensure its GxP effectiveness and compliance.

¡°Unifying quality processes, content, and training on ³Ô¹Ï±¬ÁÏ Quality Cloud will help Recipharm keep contract development and manufacturing on track as it continues to scale,¡± said Rob Gaertner, vice president of quality strategy for Europe at ³Ô¹Ï±¬ÁÏ. ¡°We¡¯re excited to partner with Recipharm in evolving its quality operations.¡±

About ³Ô¹Ï±¬ÁÏ Systems
³Ô¹Ï±¬ÁÏ is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, ³Ô¹Ï±¬ÁÏ serves more than 1,000 customers, ranging from the world¡¯s largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, ³Ô¹Ï±¬ÁÏ is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com/eu.

³Ô¹Ï±¬ÁÏ Forward-looking Statements
This release contains forward-looking statements regarding ³Ô¹Ï±¬ÁÏ¡¯s products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended October 31, 2023, which you can find (a summary of risks which may impact our business can be found on pages 38 and 39), and in our subsequent SEC filings, which you can access at .

###

Contact:
Jeremy Whittaker
³Ô¹Ï±¬ÁÏ Systems
+49-695-095-5486
jeremy.whittaker@veeva.com

Powerful Community, Fresh Ideas

Copenhagen | 28-29 May, 2026

Learn more